You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The test, based on the next generation of a spinning disk platform, detects three enterotoxins and DNA from three enteric pathogens.
The assay was shown to have a simpler workflow and was able to detect mosaicism, with only a slight decrease in sensitivity compared to a lab-developed test.
The new plant will serve as the company's hub for launching multiplexed molecular diagnostic kits for tuberculosis and other infectious disease.
A proof-of-concept version of the method takes less than eight hours to perform ID-AST directly from whole blood.
The Ann Arbor, Michigan-based firm will compete with a few well-established players offering systems that can run in vitro diagnostic tests as well as lab-developed tests.
The San Diego-based firm's diagnostic system uses spatial thermal cycling and a proprietary liquid metal bath for temperature control for five-minute multiplexed PCR assays.
The San Diego-based company is ramping up efforts to market its handheld molecular influenza test in anticipation of the upcoming flu season.
The portable, battery-operated system will be an interim solution for decentralized testing in places where power may be unreliable.
Formerly known as SlipChip Corp, the firm has recently won nearly $10 million in funding to hone its approaches to sepsis and CT/NG testing.
The observational study showed delays to diagnosis reduced the chances of identifying pathogens and generally led to poorer outcomes.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.